company background image
300122 logo

Chongqing Zhifei Biological Products SZSE:300122 Voorraadrapport

Laatste prijs

CN¥28.25

Marktkapitalisatie

CN¥67.6b

7D

-7.3%

1Y

-56.8%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Chongqing Zhifei Biological Products Co., Ltd.

SZSE:300122 Voorraadrapport

Marktkapitalisatie: CN¥67.6b

Chongqing Zhifei Biological Products Co., Ltd. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Chongqing Zhifei Biological Products
Historische aandelenkoersen
Huidige aandelenkoersCN¥28.25
52 Week HoogtepuntCN¥70.27
52 Week LaagCN¥20.38
Bèta0.92
11 maand verandering-15.37%
3 maanden verandering3.48%
1 Jaar Verandering-56.80%
33 jaar verandering-66.86%
5 jaar verandering-10.79%
Verandering sinds IPO339.69%

Recent nieuws en updates

Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Sep 30
Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Recent updates

Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Sep 30
Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122) Analysts Are More Bearish Than They Used To Be

Sep 03
Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122) Analysts Are More Bearish Than They Used To Be

Calculating The Fair Value Of Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122)

Aug 23
Calculating The Fair Value Of Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122)

We Think Chongqing Zhifei Biological Products (SZSE:300122) Can Stay On Top Of Its Debt

Jul 26
We Think Chongqing Zhifei Biological Products (SZSE:300122) Can Stay On Top Of Its Debt

Why Investors Shouldn't Be Surprised By Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Low P/E

May 21
Why Investors Shouldn't Be Surprised By Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Low P/E

Earnings Miss: Chongqing Zhifei Biological Products Co., Ltd. Missed EPS By 35% And Analysts Are Revising Their Forecasts

Apr 26
Earnings Miss: Chongqing Zhifei Biological Products Co., Ltd. Missed EPS By 35% And Analysts Are Revising Their Forecasts

Is Chongqing Zhifei Biological Products (SZSE:300122) A Risky Investment?

Mar 26
Is Chongqing Zhifei Biological Products (SZSE:300122) A Risky Investment?

Rendement voor aandeelhouders

300122CN BiotechsCN Markt
7D-7.3%-4.1%-1.2%
1Y-56.8%-16.9%3.1%

Rendement versus industrie: 300122 underperformed the CN Biotechs industry which returned -16.9% over the past year.

Rendement versus markt: 300122 underperformed the CN Market which returned 3.1% over the past year.

Prijsvolatiliteit

Is 300122's price volatile compared to industry and market?
300122 volatility
300122 Average Weekly Movement11.9%
Biotechs Industry Average Movement8.9%
Market Average Movement7.9%
10% most volatile stocks in CN Market12.0%
10% least volatile stocks in CN Market5.4%

Stabiele aandelenkoers: 300122's share price has been volatile over the past 3 months compared to the CN market.

Volatiliteit in de loop van de tijd: 300122's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
20027,365Rensheng Jiangwww.zhifeishengwu.com

Chongqing Zhifei Biological Products Co., Ltd. houdt zich bezig met onderzoek, ontwikkeling, productie, marketing, distributie, import en export van vaccins en biologische producten in China. Het bedrijf biedt ook diensten aan op het gebied van gekoelde opslag.

Chongqing Zhifei Biological Products Co., Ltd. Samenvatting

Hoe verhouden de winst en inkomsten van Chongqing Zhifei Biological Products zich tot de beurswaarde?
300122 fundamentele statistieken
MarktkapitalisatieCN¥67.62b
Inkomsten(TTM)CN¥3.69b
Inkomsten(TTM)CN¥36.43b

18.3x

Koers/Winstverhouding

1.9x

P/S-verhouding

Is 300122 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
300122 resultatenrekening (TTM)
InkomstenCN¥36.43b
Kosten van inkomstenCN¥27.41b
BrutowinstCN¥9.02b
Overige uitgavenCN¥5.33b
InkomstenCN¥3.69b

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)1.54
Brutomarge24.77%
Nettowinstmarge10.13%
Schuld/Eigen Vermogen Verhouding28.8%

Hoe presteerde 300122 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

2.8%

Huidig dividendrendement

52%

Uitbetalingsratio